Latest news

19 March 2019

The most important lessons from Barcelona

The Annual EAU Congress typically closes with a Souvenir Session, and EAU19 in Barcelona was no different. Presided over by
18 March 2019

AUA Lecture challenges urologists to get more out of patient-reported outcome

When determining which treatment a patient should receive for localised prostate cancer, urologists should be prepared to not just compare
18 March 2019

Primary results from the SAUL study

Prof. Jens Bedke (DE) and Prof. Maria José Ribal discussed the primary results from the SAUL study with Prof. Axel
18 March 2019

Case deliberations: To treat or not to treat with testosterone therapy?

Testosterone therapy (TTH) as a plausible treatment for a patient was examined during “Plenary Session 06: The role of the
18 March 2019

Breaking News Session: Prostate & Bladder Cancer trials

This Monday, the last full day of EAU19 in Barcelona, Prof. Axel Merseburger (DE) presented the results of the SAUL
18 March 2019

Thematic session highlights hot onco-urology updates

Conclusions from recent oncology meetings were summarised during “Thematic Session 11: Latest and hot news in medical treatment in onco-urology”,
17 March 2019

EUT Congress News – Monday 18 March 2019

Read the news and backgrounds from day 3 at EAU19 in Barcelona.
17 March 2019

Daily Debate: Imaging in Urology

Dr. Sanchez-Salas (FR) and Prof. Murphy (AU) discussed recent changes in the diagnostic pathway of clinically localized prostate cancer. In
17 March 2019

OAB: Current options and future challenges

A panel of OAB experts convened in Barcelona on Sunday, presiding over a series of state-of-the-art lectures and case presentations.
17 March 2019

Renal Cell Carcinoma: Controversies in care

“The only thing that is permanent in surgery is change,” remarked Prof. Alexandre Mottrie (BE), launching the first debate in
17 March 2019

Focal therapy: Promising or insufficient?

Focal therapy is a general term for a variety of non-invasive techniques aimed at destroying small tumours inside the prostate,
17 March 2019

Is MRI-targeted biopsy enough?

Opposing views on the efficacy and significance of MRI-targeted biopsy were presented during “Is MRI-targeted biopsy enough?” the first debate
17 March 2019

Breaking News: New PCa drugs and imaging